These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Design and evaluation of novel oxadiazole derivatives as potential prostate cancer agents. Mochona B; Qi X; Euynni S; Sikazwi D; Mateeva N; Soliman KF Bioorg Med Chem Lett; 2016 Jun; 26(12):2847-2851. PubMed ID: 27156770 [TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and in vitro anticancer activity of novel quinoline and oxadiazole derivatives of ursolic acid. Gu W; Jin XY; Li DD; Wang SF; Tao XB; Chen H Bioorg Med Chem Lett; 2017 Sep; 27(17):4128-4132. PubMed ID: 28733083 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and anticancer activity of new dihydropyrimidinone derivatives. Mostafa AS; Selim KB Eur J Med Chem; 2018 Aug; 156():304-315. PubMed ID: 30015070 [TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, anticancer evaluation, molecular docking and cell cycle analysis of 3-methyl-4,7-dihydropyrazolo[1,5-a]pyrimidine derivatives as potent histone lysine demethylases (KDM) inhibitors and apoptosis inducers. Metwally NH; Mohamed MS; Ragb EA Bioorg Chem; 2019 Jul; 88():102929. PubMed ID: 31015179 [TBL] [Abstract][Full Text] [Related]
14. Discovery of coumarin-monastrol hybrid as potential antibreast tumor-specific agent. Sashidhara KV; Avula SR; Sharma K; Palnati GR; Bathula SR Eur J Med Chem; 2013 Feb; 60():120-7. PubMed ID: 23287057 [TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and in vitro antitumor activity of new 1,4-diarylimidazole-2-ones and their 2-thione analogues. Congiu C; Cocco MT; Onnis V Bioorg Med Chem Lett; 2008 Feb; 18(3):989-93. PubMed ID: 18164978 [TBL] [Abstract][Full Text] [Related]
16. Synthesis, thymidine phosphorylase inhibitory and computational study of novel 1,3,4-oxadiazole-2-thione derivatives as potential anticancer agents. Bajaj S; Roy PP; Singh J Comput Biol Chem; 2018 Oct; 76():151-160. PubMed ID: 30015176 [TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and bioactivity of dihydropyrimidine derivatives as kinesin spindle protein inhibitors. Tawfik HO; El-Moselhy TF; El-Din NS; El-Hamamsy MH Bioorg Med Chem; 2019 Dec; 27(23):115126. PubMed ID: 31648875 [TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of thienopyrimidine urea derivatives with potential cytotoxic and pro-apoptotic activity against breast cancer cell line MCF-7. Abdelhaleem EF; Abdelhameid MK; Kassab AE; Kandeel MM Eur J Med Chem; 2018 Jan; 143():1807-1825. PubMed ID: 29133058 [TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, biological evaluation and molecular docking of new 1,3,4-oxadiazole homonucleosides and their double-headed analogs as antitumor agents. El Mansouri AE; Oubella A; Mehdi A; AitItto MY; Zahouily M; Morjani H; Lazrek HB Bioorg Chem; 2021 Mar; 108():104558. PubMed ID: 33358270 [TBL] [Abstract][Full Text] [Related]
20. Discovery of a series of 1,3,4-oxadiazole-2(3H)-thione derivatives containing piperazine skeleton as potential FAK inhibitors. Sun J; Ren SZ; Lu XY; Li JJ; Shen FQ; Xu C; Zhu HL Bioorg Med Chem; 2017 May; 25(9):2593-2600. PubMed ID: 28363444 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]